LUCHINI, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 12.737
EU - Europa 11.436
AS - Asia 9.471
SA - Sud America 1.737
Continente sconosciuto - Info sul continente non disponibili 790
AF - Africa 389
OC - Oceania 27
Totale 36.587
Nazione #
US - Stati Uniti d'America 12.321
RU - Federazione Russa 4.720
SG - Singapore 3.746
CN - Cina 2.431
IT - Italia 1.838
GB - Regno Unito 1.717
BR - Brasile 1.353
HK - Hong Kong 987
VN - Vietnam 873
DE - Germania 614
IE - Irlanda 572
FR - Francia 542
SE - Svezia 471
BD - Bangladesh 369
FI - Finlandia 294
KR - Corea 294
CA - Canada 205
IN - India 152
NL - Olanda 144
AR - Argentina 137
JP - Giappone 120
MX - Messico 104
UA - Ucraina 97
TR - Turchia 78
NG - Nigeria 73
ID - Indonesia 72
AT - Austria 70
EC - Ecuador 69
ES - Italia 67
ZA - Sudafrica 64
BJ - Benin 60
PL - Polonia 59
TG - Togo 54
IQ - Iraq 53
VE - Venezuela 43
BE - Belgio 39
CO - Colombia 34
MA - Marocco 34
PK - Pakistan 34
CL - Cile 28
PH - Filippine 28
PY - Paraguay 28
UZ - Uzbekistan 28
SA - Arabia Saudita 23
CZ - Repubblica Ceca 22
MY - Malesia 22
CH - Svizzera 21
KE - Kenya 21
AU - Australia 20
PE - Perù 19
TN - Tunisia 19
JM - Giamaica 18
CR - Costa Rica 16
HR - Croazia 16
AE - Emirati Arabi Uniti 15
JO - Giordania 14
LT - Lituania 13
AL - Albania 12
AZ - Azerbaigian 12
EG - Egitto 12
IR - Iran 12
LV - Lettonia 12
NI - Nicaragua 12
NP - Nepal 12
UY - Uruguay 12
BO - Bolivia 11
KZ - Kazakistan 11
OM - Oman 11
PT - Portogallo 11
DZ - Algeria 10
RO - Romania 10
RS - Serbia 10
SK - Slovacchia (Repubblica Slovacca) 10
KG - Kirghizistan 9
HN - Honduras 8
IL - Israele 8
SV - El Salvador 8
TH - Thailandia 8
BY - Bielorussia 7
LB - Libano 7
NO - Norvegia 7
PS - Palestinian Territory 7
SN - Senegal 7
CY - Cipro 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
GT - Guatemala 6
HU - Ungheria 6
SI - Slovenia 6
AM - Armenia 5
BB - Barbados 5
TT - Trinidad e Tobago 5
AO - Angola 4
BG - Bulgaria 4
DK - Danimarca 4
EE - Estonia 4
GA - Gabon 4
MK - Macedonia 4
NZ - Nuova Zelanda 4
PA - Panama 4
Totale 35.714
Città #
Singapore 1.856
Ashburn 1.592
Moscow 1.583
Dallas 1.412
San Jose 1.369
Southend 1.351
Chandler 1.045
Hong Kong 939
Verona 759
Council Bluffs 602
Dublin 543
Beijing 507
The Dalles 481
New York 389
Jacksonville 292
Ho Chi Minh City 286
Woodbridge 268
Los Angeles 247
Ann Arbor 203
Houston 191
Princeton 182
Lawrence 181
Munich 178
Hanoi 175
Santa Clara 160
Wilmington 148
São Paulo 143
Buffalo 134
Milan 131
Helsinki 124
Redondo Beach 123
Jinan 118
Nanjing 112
London 104
Columbus 103
Tokyo 101
Shenyang 91
Redmond 86
Sindelfingen 82
Rome 72
Abuja 71
Montreal 70
Seattle 69
Orem 66
Hebei 61
Cotonou 60
Tianjin 58
Turku 58
Phoenix 57
Guangzhou 55
Zhengzhou 55
Lomé 54
Amsterdam 51
Rio de Janeiro 51
Warsaw 50
Ningbo 49
Changsha 48
Da Nang 48
Redwood City 47
Hangzhou 46
Nuremberg 46
Bologna 45
Seoul 45
Toronto 45
Frankfurt am Main 44
Chicago 43
Johannesburg 43
Brooklyn 42
Shanghai 42
Stockholm 42
Taizhou 42
Vienna 40
Atlanta 39
Brussels 39
Haikou 39
Taiyuan 38
Chennai 37
Haiphong 37
Lancaster 37
San Francisco 36
Washington 36
Mexico City 35
Nanchang 35
Lappeenranta 33
Poplar 33
Denver 32
Naples 32
Paris 31
Belo Horizonte 30
Brasília 29
Falkenstein 29
Jakarta 29
Jiaxing 28
Madrid 26
Boston 24
Florence 24
Boardman 23
Mumbai 23
Dong Ket 22
Charlotte 21
Totale 20.983
Nome #
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 298
A rare case of three different tumors in the same pancreatic specimen: a case report and brief review of the literature 263
Genomic characterization of hepatoid tumors: context matters 262
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 250
Tumor-like lesionsof the pancreas. 244
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 242
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 229
CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas 221
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 221
Adherence to the Mediterranean diet is associated with better quality of life: data from the Osteoarthritis Initiative 218
Adenocarcinoma of the paraurethral glands: a case report 216
Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature 215
CD71 in Gestational Pathology: A Versatile Immunohistochemical Marker With New Possible Applications 208
Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment 207
Sex differences in oncogenic mutational processes 207
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 205
Different Prognostic Roles Of Tumor Suppressor Gene BAP1 In Cancer: A Systematic Review With Meta-Analysis 203
Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis 203
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 203
Ampulla of Vater carcinoma: Molecular landscape and clinical implications 203
Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis 202
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 200
Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data 198
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 198
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis 196
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 196
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 196
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 191
Epstein-Barr Virus-associated gastric cancer: a histopathologic study with comprehensive molecular profiling 191
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 191
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 190
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 187
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 186
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma 186
CD13 is a useful tool in the differential diagnosis of meningiomas with potential biological and prognostic implications 185
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms 183
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells 183
Fhit down-regulation is an early event in pancreatic carcinogenesis 181
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance 181
Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis 179
Tracheobronchopathia Osteochondroplastica: A Case Report Illustrating the Importance of Multilevel Workup Clinical, Endoscopic and Histological Assessment in Diagnosis of an Uncommon Disease 178
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications 178
Specific expression patterns of epithelial to mesenchymal transition factors in gestational molar disease 176
Ampullary Neuroendocrine Neoplasms: Identification of Prognostic Factors in a Multicentric Series of 119 Cases 173
Adherence to a Mediterranean diet is associated with lower prevalence of osteoarthritis: Data from the osteoarthritis initiative 172
Pathological complete response in a patient affected by multiple synchronous, breast and lung primary malignancies: a case report and review of the literature 170
ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR 169
Loss of FGFR4 promotes the malignant phenotype of PDAC 168
Extranodal extension in N1-adenocarcinoma of the pancreas and papilla of Vater: a systematic review and meta-analysis of its prognostic significance 168
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 168
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 167
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 166
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 166
Heterogeneity of predictive biomarker expression in gastric and esophago-gastric junction carcinoma with peritoneal dissemination 165
Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in non-functional pancreatic neuroendocrine tumors 164
Surgery for pancreatic neuroendocrine tumors during the COVID-19 pandemic: a retrospective cohort from a high-volume center 164
Extranodal extension is an important prognostic parameter for both colonic and rectal cancer 164
Exosomal miRNA signatures of pancreatic lesions 164
High-risk Pancreatic Anastomosis vs. Total Pancreatectomy after Pancreatoduodenectomy: Postoperative Outcomes and Quality of Life Analysis 164
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation 163
ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol 163
Hepatoid tumors of the gastrointestinal/pancreatobiliary district: morphology, immunohistochemistry, and molecular profiles 161
Next-Generation Histopathologic Diagnosis: A Lesson From a Hepatic Carcinosarcoma 161
Serous Neoplasms 160
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 159
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants 159
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 158
Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma 158
From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer 158
Metastatic malignant melanoma to the gallbladder. Case report and review of the literature 157
Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms 157
CARATTERISTICHE CLINICO-PATOLOGICHE, PROFILO MOLECOLARE E BERSAGLI PER L’IMMUNOTERAPIA NEI CARCINOMI INDIFFERENZIATI DEL PANCREAS CON CELLULE GIGANTI SIMIL-OSTEOCLASTICHE 156
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis 156
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases 156
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection 155
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach 155
Either High or low Risk: The Acinar Score at the Resection Margin Dichotomizes the Risk Spectrum Of Pancreas-specific Complications After Pancreatoduodenectomy 154
Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapy 154
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities 154
Inflammatory and tumor-like lesions of the pancreas 154
Malignant epithelial/exocrine tumors of the pancreas 154
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 153
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites 153
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 153
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization 152
Long-term organoid culture of a small intestinal neuroendocrine tumor 152
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 151
Mucinous Neoplasms 150
Artificial intelligence in oncology: current applications and future perspectives 150
Circulating tumour DNA: a challenging innovation to develop "precision onco-surgery" in pancreatic adenocarcinoma 150
Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for multiple disease dimensions 148
Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma 147
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association 147
Artificial Intelligence for Predicting Microsatellite Instability Based on Tumor Histomorphology: A Systematic Review 146
Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary 144
Fatty pancreas disease: an integrated study on frozen tissues shows distinct compartments of inter/intra-lobular, intra-acinar, and intra-islet fat deposition 144
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer 143
Evaluating Mismatch Repair Deficiency for Solid Tumor Immunotherapy Eligibility: Immunohistochemistry versus Microsatellite Molecular Testing 143
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial 142
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence 142
Totale 17.794
Categoria #
all - tutte 137.227
article - articoli 132.247
book - libri 0
conference - conferenze 677
curatela - curatele 0
other - altro 444
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.859
Totale 274.454


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022982 0 0 66 123 35 36 43 129 68 39 95 348
2022/20233.134 206 333 284 520 250 777 51 205 352 40 74 42
2023/20242.166 92 166 161 222 233 318 198 152 40 96 369 119
2024/20256.034 324 282 259 912 301 211 377 317 867 466 564 1.154
2025/202618.294 1.234 997 1.634 2.785 4.249 1.043 1.509 1.110 1.560 1.039 484 650
2026/20271.354 421 705 228 0 0 0 0 0 0 0 0 0
Totale 36.587